Avitas Wealth Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-5,810
Closed -$737K 195
2021
Q3
$737K Sell
5,810
-123
-2% -$17.9K 0.13% 148
2021
Q2
$987K Sell
5,933
-14,246
-71% -$2.31M 0.18% 141
2021
Q1
$3.67M Sell
20,179
-2,412
-11% -$559K 0.72% 44
2020
Q4
$4.52M Buy
22,591
+7,859
+53% +$1.6M 0.91% 23
2020
Q3
$3.23M Sell
14,732
-8,044
-35% -$1.7M 0.9% 33
2020
Q2
$4.35M Sell
22,776
-4,405
-16% -$772K 1.44% 12
2020
Q1
$4.21M Sell
27,181
-1,897
-7% -$221K 1.92% 10
2019
Q4
$2.43M Buy
29,078
+302
+1% +$23K 0.62% 70
2019
Q3
$1.95M Buy
28,776
+10,468
+57% +$689K 0.54% 82
2019
Q2
$1.22M Buy
+18,308
New +$1.07M 0.34% 101

Other funds holding TDOC

Avitas Wealth Management's TDOC Position: Q4 2021 in Review

Avitas Wealth Management sold out of Teladoc Health (TDOC) in Q4 2021, closing a stake of 5,810 shares — an estimated $737K sold.

Avitas Wealth Management first reported a position in TDOC in Q2 2019 and held it in 10 quarters. The position peaked at $4.52M in Q4 2020. 729 funds tracked by Wall St. Rank hold TDOC as of Q4 2021.

  • Avitas Wealth Management reported no remaining Teladoc Health position as of Q4 2021 after selling out during the quarter.
  • Avitas Wealth Management sold 5,810 Teladoc Health shares in Q4 2021, an estimated $737K.
  • Avitas Wealth Management first reported a position in Teladoc Health in Q2 2019 and held it in 10 quarters.
  • Avitas Wealth Management's Teladoc Health position peaked at $4.52M in Q4 2020.
  • 729 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2021.

Based on Avitas Wealth Management's 13F filing for Q4 2021, filed 26 Jan 2022.